Accueil>>Lipids>> P450>>(±)5(6)-EET-d11

(±)5(6)-EET-d11 (Synonyms: (±)5,6-EET-d11)

Catalog No.GC46262

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

(±)5(6)-EET-d11 Chemical Structure

Cas No.: N/A

Taille Prix Stock Qté
10 μg
168,00 $US
En stock
25 μg
399,00 $US
En stock
50 μg
756,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

5(6)-EET-d11 is intended for use as an internal standard for the quantification of (±)5(6)-EET by GC- or LC-MS. 5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.1,2 In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS.3 In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion.4,5 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhibits isoforms Cav3.1, Cav3.2 (IC50 = 0.54 µM), and Cav3.3 and decreases nifedipine-resistant phenylephrine-induced vasoconstriction in isolated mouse mesenteric arteries via Cav3.2 blockade when used at a concentration of 3 µM.6 In addition, it is a substrate of COX-1 and COX-2, as measured by oxygen consumption and product formation assays when used at a concentration of 50 µM.7 (±)5(6)-EET-d11 is provided as a mixture of the free acid and lactone.

1.Chacos, N., Falck, J.R., Wixtrom, C., et al.Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acidBiochem. Biophys. Res. Commun.104(3)916-922(1982) 2.Oliw, E.H., Guengerich, F.P., and Oates, J.A.Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediatesJ. Biol. Chem.257(7)3771-3781(1982) 3.Rashid, M., Manivet, P., Nishio, H., et al.Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modelingLife Sci.73(2)193-207(2003) 4.Snyder, C., Lattanzio, F., Yadagiri, P., et al.5,6-Epoxyeicosatrienoic acid mobilizes Ca2+ in anterior pituitary cellsBiochem. Biophys. Res. Commun.139(3)1188-1194(1986) 5.Falck, J.R., Manna, S., Moltz, J., et al.Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic isletsBiochem. Biophys. Res. Commun.114(2)743-749(1983) 6.Cazade, M., Bidaud, I., Hansen, P.B., et al.5,6-EET potently inhibits T-type calcium channels: Implication in the regulation of the vascular tonePflugers Arch.466(9)1759-1768(2014) 7.Rand, A.A., Barnych, B., Morisseau, C., et al.Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acidsProc. Natl. Acad. Sci. USA114(17)4370-4375(2017)

Avis

Review for (±)5(6)-EET-d11

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)5(6)-EET-d11

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.